Don’t Jump to Ticagrelor Plus Aspirin After Stroke
October 2020
You’ll hear ticagrelor (Brilinta) plus aspirin promoted after a MINOR ischemic stroke or high-risk TIA.
New evidence shows that taking this combo for 30 days after a minor stroke or high-risk TIA decreases the composite of death or stroke in 1 in 91 patients...compared to aspirin monotherapy.
But the benefit is mostly from reducing stroke risk...the combo doesn’t seem to reduce mortality alone OR improve disability scores.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote